Dr Dilip A. Bhuva joined Xyfil Ltd. in Dec, 2014 a then start-up company that manufactures nicotine containing liquids for use in ENDS. Upon his appointment, he was tasked with designing and commissioning various systems that granted data management, production, batch traceability, quality control and quality assurance abilities to ensure production of high quality, consistent and safe products. He was quickly promoted to the post of Chief Science and Compliance Officer and played a vital role in establishing and developing the compliance arm of the business. He currently heads the compliance department and has enabled the company to provide TPD2 services to some very well-known brands in the ENDS market, including e-liquid and hardware brands.
He has keen interest in the analysis of ENDS products and together with Xyfil’s partner laboratory, he has played a key role in guiding the development of seven analytical methods – using various techniques such as LC-MS, GC-MS, GC-FID, HPLC-UV, ICP-OES, and KF – that are specifically developed and validated for ENDS market. He has also developed and improved upon emissions collection methods that mimic real-world usage patterns; this system is currently under the UK patent process. He also authored various documents on behalf of the company including CLP classification of ENDS products, the first publicly available document with complete and accurate classification for e-liquid products.
He also regularly engages in scientific correspondence with various government agencies such as MHRA, European Chemicals Agency, and EU Committee for Risk Assessment providing some crucial contribution on various topics including regulation, toxicological assessment and harmonised classification of chemicals used in ENDS industry. Among other achievements, he has successfully thwarted attempts to incorrectly classify propylene glycol as a respiratory irritant, at the EU level.
Prior to Xyfil, Dilip supervised and trained several BSc, MSc, MRes students and a PhD student in their individual research projects at the University of Central Lancashire (UCLan). He was awarded a PhD in Neuroscience from UCLan for his work that elucidated some of the cellular and extracellular processes involved in distinct modes of synaptic exocytosis in the Central Nervous System. For his PhD, he received scholarship under the reputable Overseas Research Students Associate Scheme. Dilip earned a First Class BSc degree in Molecular and Cellular Biology from UCLan. He has presented papers at many international conferences.